Arbutus Biopharma (ABUS) Times Interest Earned (2017 - 2025)
Arbutus Biopharma (ABUS) has disclosed Times Interest Earned for 9 consecutive years, with -$293.89 as the latest value for Q4 2025.
- Quarterly Times Interest Earned rose 36.72% to -$293.89 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$393.4 through Dec 2025, up 29.38% year-over-year, with the annual reading at -$393.4 for FY2025, 29.38% up from the prior year.
- Times Interest Earned hit -$293.89 in Q4 2025 for Arbutus Biopharma, up from -$376.48 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of $53.14 in Q2 2025 to a low of -$917.82 in Q1 2025.
- Historically, Times Interest Earned has averaged -$261.04 across 5 years, with a median of -$97.73 in 2023.
- Biggest five-year swings in Times Interest Earned: plummeted 1028.81% in 2023 and later skyrocketed 108.37% in 2025.
- Year by year, Times Interest Earned stood at -$37.14 in 2021, then tumbled by 96.62% to -$73.02 in 2022, then tumbled by 545.78% to -$471.52 in 2023, then rose by 1.5% to -$464.43 in 2024, then surged by 36.72% to -$293.89 in 2025.
- Business Quant data shows Times Interest Earned for ABUS at -$293.89 in Q4 2025, -$376.48 in Q3 2025, and $53.14 in Q2 2025.